Ozempic: From Miracle Drug to Market Earthquake
1 August - 22 mins
Podcast Series
Newstalk Daily
It’s been hailed as a miracle cure for obesity, name-dropped by Elon Musk, and whispered about behind the velvet ropes of Hollywood. Now, Ozempic is at the centre of a €60 billion market shock that’s shaken not just the pharmaceutical world but the wider economy.
In today’s podcast, Ciara Doherty is joined by economist and broadcaster Susan Hayes Culleton, host of Taking Stock, to unpack the extraordinary rise of Ozempic - and what the crash in the share price of its manufacturer, Novo Nordisk, tells us about hype, health and high finance in 2025.
From its roots as a diabetes drug to becoming the go-to injection for rapid weight loss, Ozempic’s journey has captured the imagination of soc...
Series Episodes
